跳至主要内容
临床试验/NCT05919511
NCT05919511招募中不适用

A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

Incyte Corporation56 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,500
试验地点
56
主要终点
Overall Burden of cGVHD diagnosis and severity

研究概览

简要总结

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years inclusive at the time of signing the ICF
  • Allogeneic SCT 90 to 180 days prior to enrollment
  • Able to comprehend and willing to provide informed consent
  • Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

排除标准

  • There are no exclusion criteria for this study

结局指标

主要结局

Overall Burden of cGVHD diagnosis and severity

时间窗: 36 months

次要结局

  • To describe personal and healthcare resources associated with the management of cGVHD(36 months)
  • To describe changes in the proteomic, cytologic and molecular profile in blood, serum and saliva cGVHD(Up to 36 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (56)

Loading locations...

相似试验